Recruiting × Carcinoma, Renal Cell × Gastrointestinal × Clear all A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Phase 1/2 Recruiting
60 enrolled
STELLAR-002
Phase 1 Recruiting
1,314 enrolled
PNeoVCA
Phase 1/2 Recruiting
132 enrolled
ELEPHAS-04
Recruiting
324 enrolled
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Recruiting
500 enrolled
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Phase 1 Recruiting
307 enrolled
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Phase 1/2 Recruiting
134 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
DP-04
Recruiting
100 enrolled
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Phase 1 Recruiting
240 enrolled
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Phase 1/2 Recruiting
159 enrolled
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
450 enrolled
BASECAMP-1
Recruiting
200 enrolled
A Study of MGC026 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
250 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
Sapu003 in Advanced mTOR-sensitive Solid Tumors
Phase 1 Recruiting
27 enrolled
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Phase 1/2 Recruiting
124 enrolled
FIT-001
Phase 1 Recruiting
300 enrolled
ELEPHAS-02
Recruiting
416 enrolled
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2 Recruiting
27 enrolled
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
158 enrolled
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Phase 1 Recruiting
130 enrolled
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Phase NA Recruiting
26 enrolled
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Phase 2 Recruiting
50 enrolled
PSI-Immune
Phase 2 Recruiting
480 enrolled
Indocyanine Green (ICG) Guided Tumor Resection
Phase 1 Recruiting
230 enrolled
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Phase NA Recruiting
40 enrolled
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
Phase 1/2 Recruiting
270 enrolled
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
Phase 1 Recruiting
130 enrolled
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
Phase 1 Recruiting
67 enrolled
ST-ICI02
Recruiting
200 enrolled
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Phase 1/2 Recruiting
126 enrolled
TraveraRTGx
Recruiting
200 enrolled
A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors
Phase 1/2 Recruiting
76 enrolled
DENALI-1
Phase 1/2 Recruiting
240 enrolled
ORACLE
Recruiting
2,020 enrolled
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
Phase 1/2 Recruiting
40 enrolled
MOIO
Phase 3 Recruiting
646 enrolled
A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
Phase 1 Recruiting
214 enrolled
The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors
Phase 1 Recruiting
100 enrolled
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Phase NA Recruiting
2,996 enrolled
A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.
Phase 1 Recruiting
24 enrolled
First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours
Phase 1 Recruiting
40 enrolled
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Phase 2 Recruiting
178 enrolled
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Phase 1/2 Recruiting
358 enrolled
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Recruiting
2,700 enrolled
Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms
Recruiting
500 enrolled
ONFM-SBRT
Recruiting
57 enrolled
GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Phase 1/2 Recruiting
125 enrolled